ATE74011T1 - Pharmazeutische produkte. - Google Patents

Pharmazeutische produkte.

Info

Publication number
ATE74011T1
ATE74011T1 AT87310550T AT87310550T ATE74011T1 AT E74011 T1 ATE74011 T1 AT E74011T1 AT 87310550 T AT87310550 T AT 87310550T AT 87310550 T AT87310550 T AT 87310550T AT E74011 T1 ATE74011 T1 AT E74011T1
Authority
AT
Austria
Prior art keywords
pharmaceutical products
interferon
pro
chem
simultaneous
Prior art date
Application number
AT87310550T
Other languages
English (en)
Inventor
Martin Cole
Malcolm Richard Beecham P Boyd
Road Bottom
David Beecham Pharmaceu Sutton
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Application granted granted Critical
Publication of ATE74011T1 publication Critical patent/ATE74011T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Formation And Processing Of Food Products (AREA)
AT87310550T 1986-12-02 1987-11-30 Pharmazeutische produkte. ATE74011T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868628826A GB8628826D0 (en) 1986-12-02 1986-12-02 Pharmaceutical products
EP87310550A EP0271270B1 (de) 1986-12-02 1987-11-30 Pharmazeutische Produkte

Publications (1)

Publication Number Publication Date
ATE74011T1 true ATE74011T1 (de) 1992-04-15

Family

ID=10608331

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87310550T ATE74011T1 (de) 1986-12-02 1987-11-30 Pharmazeutische produkte.

Country Status (16)

Country Link
US (1) US4957733A (de)
EP (1) EP0271270B1 (de)
JP (1) JP2724711B2 (de)
KR (1) KR960000432B1 (de)
AT (1) ATE74011T1 (de)
AU (1) AU606629B2 (de)
CA (1) CA1318850C (de)
DE (1) DE3777769D1 (de)
DK (1) DK166715B1 (de)
ES (1) ES2037095T3 (de)
GB (1) GB8628826D0 (de)
GR (1) GR3004487T3 (de)
IE (1) IE59943B1 (de)
NZ (1) NZ222741A (de)
PT (1) PT86232B (de)
ZA (1) ZA878983B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
DE69021791T2 (de) * 1989-06-30 1996-05-02 American Cyanamid Co Verwendung eines phagozytise-aktievierenden Stoffes : LPS oder IL-2 zur Herstellung eines Arzneimittels zur Behandlung von Staphylococcus-aureus-Infektionen bei Kühen.
JPH03124960A (ja) * 1989-10-11 1991-05-28 Mitsubishi Electric Corp 同軸形スタータ装置
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment
US6124304A (en) * 1993-10-05 2000-09-26 Smithkline Beecham Plc Penciclovir for the treatment of zoster associated pain
GB9326177D0 (en) * 1993-12-22 1994-02-23 Smithkline Beecham Plc Pharmaceuticals
GB9323404D0 (en) * 1993-11-12 1994-01-05 Smithkline Beecham Plc Pharmaceuticals
GB9615111D0 (en) * 1996-07-18 1996-09-04 Smithkline Beecham Plc Pharmaceuticals
AU5127098A (en) * 1996-11-29 1998-06-22 Smithkline Beecham Plc Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis
US6165458A (en) * 1997-12-26 2000-12-26 Pharmaderm Laboratories Ltd. Composition and method for dermal and transdermal administration of a cytokine
EP1655813A1 (de) * 2004-11-09 2006-05-10 Phoenix Contact GmbH & Co. KG Befestigung für elektrische Verbindung
AU2006230269A1 (en) 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
EP0182024B1 (de) * 1984-09-20 1991-04-03 Beecham Group Plc Purin-Derivate und ihre pharmazeutische Verwendung
US4606917A (en) * 1984-10-03 1986-08-19 Syntex (U.S.A) Inc. Synergistic antiviral composition

Also Published As

Publication number Publication date
GR3004487T3 (de) 1993-03-31
DE3777769D1 (de) 1992-04-30
AU8191287A (en) 1988-06-02
ES2037095T3 (es) 1993-06-16
ZA878983B (en) 1988-08-31
EP0271270A3 (en) 1989-09-27
DK627987A (da) 1988-06-03
KR960000432B1 (ko) 1996-01-06
DK627987D0 (da) 1987-11-30
EP0271270A2 (de) 1988-06-15
DK166715B1 (da) 1993-07-05
EP0271270B1 (de) 1992-03-25
AU606629B2 (en) 1991-02-14
IE873247L (en) 1988-06-02
PT86232B (pt) 1990-11-07
GB8628826D0 (en) 1987-01-07
NZ222741A (en) 1990-10-26
JP2724711B2 (ja) 1998-03-09
KR880007080A (ko) 1988-08-26
CA1318850C (en) 1993-06-08
IE59943B1 (en) 1994-05-04
US4957733A (en) 1990-09-18
JPS63145279A (ja) 1988-06-17
PT86232A (en) 1987-12-01

Similar Documents

Publication Publication Date Title
ZA928170B (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
DE68903031D1 (de) N-acetyl-3-fluoroneuraminsaeure als antivirales arzneimittel.
HUT46657A (en) Process for producing antitumour pharmaceutical compositions comprising sulfonyl-urea derivatives as active ingredient
ATE74011T1 (de) Pharmazeutische produkte.
FI93106C (fi) Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi
FI895983A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 2-bentsotiatsoliinijohdannaisten valmistamiseksi
ZA901572B (en) Pharmaceutical treatment
FI900145A (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
ES2043736T3 (es) Acidos 3,5-dihidroxi-heptanoicos sustituidos con (1h-pirrol-3-ilo) en posicion 7, sus correspondientes delta-lactonas y sales, procedimientos para su preparacion, su utilizacion como medicamentos, preparados farmaceuticos y productos intermedios.
IT8821570A0 (it) Impiego di derivati adenosinici per la preparazione di composizioni farmaceutiche aventi attivita' immunostimolante.
IT8740155A0 (it) Estensione dell'uso di un prodotto farmaceutico alimentare curativo
FI935388A0 (fi) Menetelmä lääkeaineena käyttökelpoisen bentsimidatsolidipyridiniumjohdannaisten valmistamiseksi
AU654670C (en) New phospholipid derivatives of nucleosides, their preparation and their use as antiviral drugs
GB8826891D0 (en) Administration of pharmaceutical products
IE882098L (en) Novel 3,5-dihydroxycarboxylic acids and their derivatives, process for their preparation, their use as medicines, pharmaceutical products and intermediate products
ES551388A0 (es) Procedimiento de preparacion de derivados 3,5-diamino-1h-1,2,4-triazoles y de sales de adicion acida farmaceuticamente aceptables de los mismos
GB8925848D0 (en) Administration of pharmaceutical products
GB8727005D0 (en) Administration of pharmaceutical products

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time